Latest Blackrock Kelso Capital Corp (BKCC)

New Post Public Reply Private Reply Replies (0) Message Board

Mar 13, 2014 at 6:01 AM

Latest Blackrock Kelso Capital Corp (BKCC) Headlines

Buy-Rated Dividend Stocks: Top 3 Companies: NPD, BKCC, CLCT
at The Street - Mon Mar 10, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

BlackRock Kelso Capital Corporation Declares Regular Quarterly Distribution of $0.26 per Share, Announces Financial Results for the Quarter and Year Ended December 31, 2013
Business Wire - Thu Mar 06, 7:01AM CST
BlackRock Kelso Capital Corporation (NASDAQ:BKCC) ("BlackRock Kelso Capital" or the "Company", "we", "us" or "our") announced today that its Board of Directors has declared a quarterly distribution of $0.26 per share payable on April 3, 2014 to stockholders of record as of March 20, 2014.

2 New Issues IPO Investors Need to Know About for This Week
Eric Volkman, The Motley Fool - Motley Fool - Sun Mar 02, 1:00PM CST
This week won't be a big one for initial public offerings, which is a little out of character for such a busy year. According to the latest figures from IPO specialists Renaissance Capital, as of the end of February 55 filings for new stock issues...

Research and Markets: Global Healthcare IT Outsourcing Market 2014-2018 Research Report
Business Wire - Fri Feb 28, 4:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/9fj53x/global_healthcare) has announced the addition of the "Global Healthcare IT Outsourcing Market 2014-2018" report to their offering.

3 Buy-Rated Dividend Stocks: PFLT, BKCC, CLCT
at The Street - Thu Feb 27, 10:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet

Fiserv to Present at Baird's 2014 Business Solutions Conference
Business Wire - Wed Feb 19, 8:00AM CST
Fiserv, Inc. (NASDAQ: FISV), a leading global provider of financial services technology solutions, announced today that its President and Chief Executive Officer, Jeffery Yabuki, will present at the Baird Business Solutions Conference on February 25, 2014 at 9:45 a.m. ET.

3 Buy-Rated Dividend Stocks Leading The Pack: BKCC, TICC, DMLP
at The Street - Tue Feb 18, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet

ALLETE Reports 2013 Financial Results
Business Wire - Fri Feb 14, 7:30AM CST
ALLETE, Inc. (NYSE: ALE) today reported 2013 earnings of $2.63 per share compared with $2.58 in 2012. Included in the 2013 results were acquisition costs of $1.0 million after-tax, or three cents per share, related to ALLETE Clean Energy's acquisition of three wind energy facilities.

BlackRock Kelso Capital Corporation to Report Fourth Quarter 2013 Earnings on March 6
Business Wire - Thu Feb 13, 3:00PM CST
BlackRock Kelso Capital Corporation (NASDAQ:BKCC) ("BlackRock Kelso Capital" or the "Company") announced today that it will report earnings for the fourth quarter 2013 on Thursday, March 6, 2014 prior to the opening of the financial markets.

Baidu, ZTE Become Tizen Partners
SinoCast - Thu Feb 13, 5:05AM CST
Open source mobile operating system Tizen declared 15 new partners including SoftBank Mobile, Sprint, Gamevil, Baidu Inc. (Nasdaq: BIDU) and ZTE Corporation (SEHK: 0763 and SZSE: 000063), covering mobile game publisher, operator, application developer, software management service provider and telecom carrier.

EC Infosystems Announces Lead Sponsorship of Energy Marketing Conference in Manhattan
Business Wire - Wed Feb 12, 7:10AM CST
EC Infosystems, a market leader in Electronic Data Exchange (EDI) and billing/Customer Information Solutions (CIS) for clients in the deregulated energy industry, today announced plans to sponsor and participate in the first annual Energy Marketing Conference on February 27 at the Affinia Hotel in Manhattan.

Zacks #1 Rank Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 8:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Thursday

Tomorrow's Ex-Dividends To Watch: NPD, DHG, CII, BKCC, IGT
at The Street - Tue Dec 17, 9:00AM CST
NPD DHG CII BKCC IGT are going ex-dividend tomorrow, Wednesday, Dec. 18, 2013, 5:00 AM ET

Fidus Investment (FDUS) in Focus: Stock Up 7.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 17, 6:37AM CST
Fidus Investment Corporation was a big mover last session, as the company saw its shares rise nearly 8% on the day.

American Capital Upped to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 05, 3:05PM CST
On Dec 2, 2013, we upgraded American Capital, Ltd. to Neutral from Underperform

Today's Research: State Street, Legg Mason, Och-Ziff Capital Management Group, and BlackRock Kelso Capital
PR Newswire - Wed Nov 27, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.

BlackRock Kelso Capital Earnings Review: 18 Days after Announcement Shares Up 3.6% (BKCC)
Comtex SmarTrend(R) - Mon Nov 25, 8:28AM CST
When BlackRock Kelso Capital (NASDAQ:BKCC) reported earnings 18 days ago on November 7th, 2013, analysts, on average, expected the company to report earnings of $0.24 on sales of $32.1 million. The company actually reported EPS of $0.22 on sales of $42.4 million, missing EPS estimates by $0.02 and beating revenue estimates by $10.3 million. Since the company's report, shares of BlackRock Kelso Capital have risen from $9.36 to $9.70, representing a gain of 3.6% in the past 18 days.

Rent-A-Center Opens Two Stores - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 4:35PM CST
Rent-A-Center announced the opening of a new store each in Dinuba, CA and Bellefontaine, OH.

Risk, Reward Balance Hercules - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 20, 12:20PM CST
On Nov 19, 2013, we reiterated our long-term Neutral recommendation on Hercules.

Rent-A-Center Expands Store Network - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 15, 9:20AM CST
Rent-A-Center announced the opening of a new store each in Wake Forest, N.C. and West Haverstraw, N.Y. on Nov 15, 2013.

BlackRock Kelso Capital Corp (BKCC) Stock Research Links

BKCC Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New American Funding Expands in Carolinas with Mullinix Move

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

Special Needs Group Partners with MAST to Enhance Accessibility

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

AtWork Welcomes Franchise Vet Sarah Goehring

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Partner Valuation Advisors Bolsters Team with Eichman

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Paradigm Therapeutics: A Beacon in Rare Diseases

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

New Data on SKYRIZI Offers Hope for Crohn's Patients

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...